{"schema_version":"secwatch.filing_event.v1","accession":"0001832511-25-000010","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.216672+00:00","generated_at":"2026-05-17T13:23:50.202757+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"P3 Health Partners Q2 revenue down 6% YoY; adj. EBITDA loss $17.1M; FY guidance lowered","bullets":["Average at-risk membership ~115,000, down 9% YoY due to network/payer rationalization.","Revenue $355.8M (-6% YoY); medical margin $30.6M ($89 PMPM). Excl. prior-period adj., medical margin $39.3M.","Adjusted EBITDA loss $17.1M ($50 PMPM); excl. prior-period adj., loss was $8.5M ($25 PMPM).","FY 2025 guidance: revenue $1.35B-$1.5B, medical margin $124M-$154M, adj. EBITDA loss $69M-$39M.","Identified $120M-$170M in additional EBITDA opportunities; three of four markets EBITDA positive/breakeven."],"urls":{"canonical":"https://secwatch.observer/filing/0001832511-25-000010","json":"https://secwatch.observer/filing/0001832511-25-000010.json","markdown":"https://secwatch.observer/filing/0001832511-25-000010.md","text":"https://secwatch.observer/filing/0001832511-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000183251125000010/0001832511-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000183251125000010/piii-20250814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:23:50.202757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}